273 related articles for article (PubMed ID: 26212008)
1. CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer.
Wu YC; Tang SJ; Sun GH; Sun KH
Oncogene; 2016 Apr; 35(16):2123-32. PubMed ID: 26212008
[TBL] [Abstract][Full Text] [Related]
2. VEGFC/VEGFR3 axis mediates TGFβ1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells.
Duan L; Ye L; Zhuang L; Zou X; Liu S; Zhang Y; Zhang L; Jin C; Huang Y
PLoS One; 2018; 13(7):e0200452. PubMed ID: 29995950
[TBL] [Abstract][Full Text] [Related]
3. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
Li X; Han J; Zhu H; Peng L; Chen Z
Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
5. CD44 silencing decreases the expression of stem cell-related factors induced by transforming growth factor β1 and tumor necrosis factor α in lung cancer: Preliminary findings.
Nurwidya F; Takahashi F; Kato M; Baskoro H; Hidayat M; Wirawan A; Takahashi K
Bosn J Basic Med Sci; 2017 Aug; 17(3):228-234. PubMed ID: 28446126
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 induces CXCL1 to promote stemness features in lung cancer.
Peng TJ; Wu YC; Tang SJ; Sun GH; Sun KH
Exp Biol Med (Maywood); 2023 Dec; 248(23):2249-2261. PubMed ID: 38158808
[TBL] [Abstract][Full Text] [Related]
7. TGFβ1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells.
Zhang F; Li T; Han L; Qin P; Wu Z; Xu B; Gao Q; Song Y
Biochem Biophys Res Commun; 2018 Feb; 496(4):1169-1175. PubMed ID: 29407170
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells.
Liu H; Cheng Q; Xu DS; Wang W; Fang Z; Xue DD; Zheng Y; Chang AH; Lei YJ
Respir Res; 2020 Oct; 21(1):287. PubMed ID: 33129326
[TBL] [Abstract][Full Text] [Related]
11. CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis.
Guan S; Zhou J
Mol Biosyst; 2017 Sep; 13(10):2116-2124. PubMed ID: 28820530
[TBL] [Abstract][Full Text] [Related]
12. CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling.
Kim N; Ryu H; Kim S; Joo M; Jeon HJ; Lee MW; Song IC; Kim MN; Kim JM; Lee HJ
Sci Rep; 2019 Dec; 9(1):18100. PubMed ID: 31792315
[TBL] [Abstract][Full Text] [Related]
13. C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway.
Guo J; Tong CY; Shi JG; Li XJ
Bioengineered; 2022 Mar; 13(3):7425-7438. PubMed ID: 35264069
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1.
Sippel TR; Johnson AM; Li HY; Hanson D; Nguyen TT; Bullock BL; Poczobutt JM; Kwak JW; Kleczko EK; Weiser-Evans MC; Nemenoff RA
Mol Cancer Res; 2019 Aug; 17(8):1748-1758. PubMed ID: 31088909
[TBL] [Abstract][Full Text] [Related]
16. Role of chemokine receptor CXCR7 in bladder cancer progression.
Hao M; Zheng J; Hou K; Wang J; Chen X; Lu X; Bo J; Xu C; Shen K; Wang J
Biochem Pharmacol; 2012 Jul; 84(2):204-14. PubMed ID: 22525723
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
19. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
Iwakiri S; Mino N; Takahashi T; Sonobe M; Nagai S; Okubo K; Wada H; Date H; Miyahara R
Cancer; 2009 Jun; 115(11):2580-93. PubMed ID: 19309748
[TBL] [Abstract][Full Text] [Related]
20. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
